Jennison Associates LLC Argenx Se Transaction History
Jennison Associates LLC
- $170 Billion
- Q3 2025
A detailed history of Jennison Associates LLC transactions in Argenx Se stock. As of the latest transaction made, Jennison Associates LLC holds 240,228 shares of ARGX stock, worth $218 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
240,228
Previous 264,647
9.23%
Holding current value
$218 Million
Previous $146 Million
21.46%
% of portfolio
0.1%
Previous 0.09%
Shares
33 transactions
Others Institutions Holding ARGX
# of Institutions
526Shares Held
26MCall Options Held
590KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...